Rapid Micro Biosystems, Inc.
RPID- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- SEC CIK
- 0001380106
No open-market purchases or sales by Rapid Micro Biosystems, Inc. insiders were filed in the last 90 days; 34 institutions reported holding it in 13F filings for Q2 2026, worth $30.3M in total; no superinvestor holds it.
13F holders, Q4 2023
Institutional positions in Rapid Micro Biosystems, Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 26
- +3 vs. Q3 2023
- Shares held
- 20.1M
- −1.36M (−6.4%) vs. Q3 2023
- Total value
- $14.9M
- −$8.31M (−35.8%) vs. Q3 2023
- New holders
- 5
- 5 more added
- Sold out
- 2
- 5 more reduced
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting RPID on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 34 | $30.3M |
| Q1 2026 | 46 | $36.0M |
| Q4 2025 | 42 | $42.5M |
| Q3 2025 | 29 | $49.5M |
| Q2 2025 | 29 | $52.3M |
| Q1 2025 | 28 | $40.4M |
| Q4 2024 | 19 | $10.8M |
| Q3 2024 | 19 | $15.6M |
| Q2 2024 | 21 | $12.2M |
| Q1 2024 | 23 | $18.2M |
| Q4 2023 | 26 | $14.9M |
| Q3 2023 | 23 | $23.2M |
| Q2 2023 | 24 | $21.9M |
| Q1 2023 | 31 | $29.9M |
| Q4 2022 | 42 | $27.7M |
| Q3 2022 | 53 | $82.8M |
| Q2 2022 | 52 | $112.2M |
| Q1 2022 | 59 | $181.0M |
| Q4 2021 | 55 | $227.9M |
| Q3 2021 | 49 | $401.4M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding Rapid Micro Biosystems, Inc.; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Resources Management Corp | 500 | $0 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 250 | $0 | 0.00% | +250 | New |
| Qube Research & Technologies Ltd | 4 | $3 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 14 | $10 | 0.00% | +14 | New |
| Advisory Services Network, LLC | 100 | $74 | 0.00% | +100 | New |
| Wells Fargo & Company | 154 | $114 | 0.00% | +8+5.5% | Added |
| Tower Research Capital LLC (TRC) | 9,807 | $7.26K | 0.00% | +6,655+211.1% | Added |
| XTX Topco Ltd | 10,463 | $7.74K | 0.00% | +10,463 | New |
| Morgan Stanley | 10,644 | $7.88K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 15,650 | $11.6K | 0.00% | −3,294−17.4% | Reduced |
| Virtu Financial LLC | 16,064 | $12.0K | 0.00% | +16,064 | New |
| Millennium Management LLC | 17,175 | $12.7K | 0.00% | −7,810−31.3% | Reduced |
| Citadel Advisors LLC | 24,135 | $17.9K | 0.00% | +7,494+45.0% | Added |
| State Street Corp | 26,074 | $19.3K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 77,887 | $58.0K | 0.00% | +55,500+247.9% | Added |
| Geode Capital Management, LLC | 155,264 | $114.9K | 0.00% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 218,287 | $161.5K | 0.00% | −729,494−77.0% | Reduced |
| Advent International Corp | 577,777 | $427.6K | 0.01% | 00.0% | Unchanged |
| Adage Capital Partners GP, L.L.C. | 700,000 | $518.0K | 0.00% | 00.0% | Unchanged |
| Vanguard Group Inc | 728,374 | $539.0K | 0.00% | +2,350+0.3% | Added |
| JPMorgan Chase & Co | 751,312 | $556.0K | 0.00% | −682,916−47.6% | Reduced |
| BlackRock Inc. | 1,021,457 | $755.9K | 0.00% | −661−0.1% | Reduced |
| ABG-WTT Global Life Science Capital Partners GP Ltd | 1,038,296 | $768.3K | 1.50% | 00.0% | Unchanged |
| Glenview Capital Management, LLC | 1,318,288 | $975.5K | 0.02% | 00.0% | Unchanged |
| Kennedy Lewis Management LP | 4,939,931 | $3.66M | 20.25% | 00.0% | Unchanged |
| Bain Capital Life Sciences Investors, LLC | 8,434,560 | $6.24M | 0.60% | 00.0% | Unchanged |
| Parkwood LLC | 0 | $0 | 0.00% | −24,511−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −15,000−100.0% | Sold out |